Pascal Krotee
Private Equity Analyst at RiverVest Venture Management LLC
Profile
Pascal joined the RiverVest team as Senior Associate in 2021.
In this role, she focuses on sourcing and completing due diligence on prospective portfolio companies in both the therapeutics and medical devices sectors.
She serves as an observer at Bluejay Therapeutics, Avalyn Pharmaceuticals, and Biolinq.
She also supports the operational activities of RiverVest’s portfolio companies.
Prior to joining the team, Pascal spent nearly 4 years as an Investment Associate at Kairos Ventures, where she focused on investments in the life sciences.
While at Kairos, she sourced new opportunities for investment, led due diligence, and served on the Board of Directors of several portfolio companies.
Like many on the RiverVest team, Pascal is a scientist by training.
She earned a Ph.D.
in Molecular Biology at UCLA, where she studied the atomic structures of proteins associated with Alzheimer’s disease and type-II diabetes and worked to create compounds that inhibited these structures.
Prior to graduate school, Pascal worked as Junior Specialist at the Development Biology Center at UC Irvine.
She earned a B.S.
in Developmental and Cell Biology with a Minor in Business Management from UC Irvine.
Pascal Krotee active positions
Companies | Position | Start |
---|---|---|
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri. | Private Equity Analyst | 2020-12-31 |
Former positions of Pascal Krotee
Companies | Position | End |
---|---|---|
Kairos Venture Investments LLC
Kairos Venture Investments LLC Investment ManagersFinance Kairos Venture Investments LLC (Kairos Venture) is a venture capital firm founded in 2015 by Jim Demetriades. The firm is headquartered in Beverly Hills, California. | Private Equity Investor | 2021-02-27 |
Holoclara, Inc.
Holoclara, Inc. Pharmaceuticals: MajorHealth Technology Holoclara, Inc. develops immunotherapy drugs to autoimmune disorders. The company was founded by Andrea Choe in March 2017 and is headquartered in Pasadena, CA. | Director/Board Member | 2021-02-27 |
Linnaeus Therapeutics, Inc.
Linnaeus Therapeutics, Inc. BiotechnologyHealth Technology Linnaeus Therapeutics, Inc. engages in identification and development of small molecule agents that modulate cellular differentiation for the treatment of cancer and disorders of pigmentation. The company was founded by Christopher Natale and Todd Ridky in 2016 and is headquartered in Haddonfield, NJ. | Director/Board Member | 2021-02-27 |
Training of Pascal Krotee
University of California | Doctorate Degree |
University of California Irvine School of Medicine | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
RiverVest Venture Management LLC
RiverVest Venture Management LLC Investment ManagersFinance RiverVest Venture Management LLC (RiverVest Venture Partners) is a venture capital firm founded in 2000 by Thomas Melzer, Craig Andrew and Jay Schmelter. The firm is headquartered in St. Louis, Missouri. | Finance |
Kairos Venture Investments LLC
Kairos Venture Investments LLC Investment ManagersFinance Kairos Venture Investments LLC (Kairos Venture) is a venture capital firm founded in 2015 by Jim Demetriades. The firm is headquartered in Beverly Hills, California. | Finance |
Linnaeus Therapeutics, Inc.
Linnaeus Therapeutics, Inc. BiotechnologyHealth Technology Linnaeus Therapeutics, Inc. engages in identification and development of small molecule agents that modulate cellular differentiation for the treatment of cancer and disorders of pigmentation. The company was founded by Christopher Natale and Todd Ridky in 2016 and is headquartered in Haddonfield, NJ. | Health Technology |
Holoclara, Inc.
Holoclara, Inc. Pharmaceuticals: MajorHealth Technology Holoclara, Inc. develops immunotherapy drugs to autoimmune disorders. The company was founded by Andrea Choe in March 2017 and is headquartered in Pasadena, CA. | Health Technology |
- Stock Market
- Insiders
- Pascal Krotee